OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Lung Cancer Research is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Radiomics and artificial intelligence in lung cancer screening	78
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications	65
Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers	65
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort	56
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts	55
A narrative review of digital pathology and artificial intelligence: focusing on lung cancer	55
Patient-derived cell line, xenograft and organoid models in lung cancer therapy	51
Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer	48
Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features	48
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy	46
Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival	46
Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer	44
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma	39
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients	39
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer	38
Clinical significance of histologic subtyping of malignant pleural mesothelioma	36
Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance—a novel technique and initial experience with 30 cases	35
Current progress and mechanisms of bone metastasis in lung cancer: a narrative review	35
Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?	33
Lung cancer screening and smoking cessation efforts	33
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms	33
Predicting the invasiveness of lung adenocarcinomas appearing as ground-glass nodule on CT scan using multi-task learning and deep radiomics	31
Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer	31
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab	31
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study	30

KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples	30
3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma	30
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1	30
Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis	30
The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility	30